The prices of leading cancer drugs have risen at rates far outstripping inflation over the last two decades, according to a new study co-authored by an MIT economist -- but the exact reasons for the cost increases are unclear.
from The Medical News http://ift.tt/1CrSYZq
from The Medical News http://ift.tt/1CrSYZq
No comments:
Post a Comment